Sections SEARCH Skip to content Skip to site index Science Subscribe Log In Log In Today’s Paper Science | How Will We Outsmart A.I. Liars? Supported by 11 Things We’d Really Like to Know For better and worse, humans are only improving their ability to deceive themselves with technology. ByCade Metz Nov. 19, 2018 During the summer before the 2016 presidential election, John Seymour and Philip Tully, two researchers with ZeroFOX, a security company in Baltimore, unveiled a new kind of Twitter bot. By analyzing patterns of activity on the social network, the bot learned to fool users into clicking on links in tweets that led to potentially hazardous sites. The bot, called SNAP_R, was an automated “phishing” system, capable of homing in on the whims of specific individuals and coaxing them toward that moment when they would inadvertently download spyware onto their machines. … [Read more...] about How Will We Outsmart A.I. Liars?
Cambridge u n i jobs
Sections SEARCH Skip to content Skip to site index Technology Subscribe Log In Log In Today’s Paper Technology | ‘I Don’t Really Want to Work for Facebook.’ So Say Some Computer Science Students. Supported by ByNellie Bowles Nov. 15, 2018 BERKELEY, Calif. — A job at Facebook sounds pretty plum. The interns make around $8,000 a month and an entry-level software engineer makes about $140,000 a year. The food is free. There’s a walking trail with indigenous plants and a juice bar. But the tone among highly sought-after computer scientists about the social network is changing. On a recent night at the University of California, Berkeley, as a group of young engineers gathered to show off their tech skills, many said they would avoid taking jobs at the social network. “I’ve heard a lot of employees who work there don’t even use it,” said Niky Arora, 19, an … [Read more...] about ‘I Don’t Really Want to Work for Facebook.’ So Say Some Computer Science Students.
Sections SEARCH Skip to content Skip to site index Obituaries Subscribe Log In Log In Today’s Paper Supported by ByKatharine Q. Seelye Nov. 8, 2018 Devah Pager, a Harvard sociologist best known for rigorously measuring and documenting racial discrimination in the labor market and in the criminal justice system, died on Nov. 2 at her home in Cambridge, Mass. She was 46. Michael Shohl, her husband, said the cause was pancreatic cancer. In her seminal work, Dr. Pager, who was the Peter and Isabel Malkin professor of public policy at the Kennedy School of Government at Harvard and a professor of sociology at the university, documented what she called the “powerful effects of race” on hiring decisions, which she said contributed to persistent inequality. Employers, she found, were more likely to hire a white man, even if he had a felony conviction, than a black man with no criminal record. “This suggests that … [Read more...] about Devah Pager, Scholar of Racial Bias in Job Market, Dies at 46
By Robin Respaut and Julie Zhu SAN FRANCISCO/HONG KONG (Reuters) - For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs to fill the pipeline of his two-week-old drug company. Crammed in tight, four-person booths executives use for private conversations, the former GlaxoSmithKline PLC <GSK.L> executive pitched dozens of U.S. biotech companies to partner with his start-up, Brii Biosciences. Months earlier, Hong had raised $260 million - much of it from Chinese and Asian investors - with a strategy to bring U.S. biotechnology drugs to China, the world’s second-largest prescription drug market and home to a rapidly growing biotech sector. Brii is now discussing partnerships with about a dozen drugmakers, which it aims to help by conducting clinical trials in China, applying for governmental approval and eventually negotiating reimbursement in a bid to capitalise on China’s stated plan to become the next global … [Read more...] about As China builds biotech sector, cash floods U.S. startups
Sections SEARCH Skip to content Skip to site index Subscribe Log In Subscribe Log In Today’s Paper Advertisement DealBook Supported by Aug. 23, 2018 Good Thursday morning. (Was this email forwarded to you? Sign up here .) Keep waiting for that killer Aramco I.P.O. Saudi Aramco’s public market debut, which would have been the biggest ever, is being postponed. Instead, the Middle Eastern oil giant is focused on buying a stake in Sabic, a huge publicly traded chemical maker controlled by the kingdom’s sovereign wealth fund. Why pause? Arranging such a huge I.P.O. is complex, and oil prices have rebounded, which made the offering less attractive. But the decision hurts several groups: • The Saudi government misses out on a multibillion-dollar windfall that it said would finance a transformation of its economy. • Bankers won’t be getting millions in advisory fees. • Stock exchanges lose the … [Read more...] about DealBook Briefing: The Biggest Ever I.P.O. Is on Hold